Clinical trials
Adenocarcinoma of Lung trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Amgen | 1 |
| Axelar AB | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Helix BioPharma Corporation | 1 |
| Morphotek | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 8 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Lung Neoplasms | 4 |
| Carcinoma, Ovarian Epithelial | 1 |
| Carcinoma, Squamous Cell | 1 |
| Cholangiocarcinoma | 1 |
| Melanoma | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
| Triple Negative Breast Neoplasms | 1 |
| Uterine Cervical Neoplasms | 1 |
Trials
Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.